+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging



Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging



American Journal of Epidemiology 172(2): 190-196



In this study, the authors aimed to investigate the prognostic value of brain-type natriuretic peptide (BNP) for all-cause mortality among persons with Chagas disease, a parasitic disease caused by the protozoan Trypanosoma cruzi. The authors used data on 1,398 participants (37.5% infected with T. cruzi) aged 60 years and over from the Bambuí Cohort Study of Aging in Brazil. From 1997 to 2007, 512 participants died, leading to 12,406 person-years of observation. The hazard ratio for death was 1.27 for each unit of log-transformed BNP level (95% confidence interval (CI: 1.11, 1.45) among infected persons, independent of potentially confounding factors. Infected persons with baseline BNP levels in the top quartile had a risk of death twice that of persons in the bottom quartile (hazard ratio = 2.07, 95% CI: 1.29, 3.32). The discriminatory ability of BNP in predicting mortality (C = 0.69, 95% CI: 0.66, 0.71) was similar to that of an electrocardiogram (C = 0.68, 95% CI: 0.65, 0.71), with reasonably stable risk discrimination over time. BNP is a strong predictor of mortality in older adults with Chagas disease. Although the usefulness of BNP for risk stratification in this parasitic disease remains a topic of debate, this study found that BNP-based risk discrimination is at least comparable to that of an electrocardiogram.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055018563

Download citation: RISBibTeXText

PMID: 20581155

DOI: 10.1093/aje/kwq106


Related references

Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging. Stroke 41(11): 2477-2482, 2010

Predictors of 10-year mortality in a population of community-dwelling Brazilian elderly: the Bambuí Cohort Study of Aging. Cadernos de Saude Publica 27(Suppl. 3): S360, 2011

Self-rated health compared with objectively measured health status as a tool for mortality risk screening in older adults: 10-year follow-up of the Bambuí Cohort Study of Aging. American Journal of Epidemiology 175(3): 228-235, 2012

Relationships between N-terminal pro B-type natriuretic peptide and incident disability and mortality in older community-dwelling adults: the Tsurugaya study. Journal of the American Geriatrics Society 58(12): 2439-2441, 2010

Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging. Journal of the American Heart Association 3(1): E000632, 2014

Physical activity and all-cause mortality among older Brazilian adults: 11-year follow-up of the Bambuí Health and Aging Study. Clinical Interventions in Aging 10: 751-758, 2015

Chagas disease and mortality in old age as an emerging issue: 10 year follow-up of the Bambuí population-based cohort study (Brazil). International Journal of Cardiology 145(2): 362-363, 2010

The "obesity paradox" in an elderly population with a high prevalence of Chagas disease: the 10-year follow-up of the Bambuí (Brazil) Cohort Study of Aging. International Journal of Cardiology 166(2): 523-526, 2013

Value of the Electrocardiographic (P Wave, T Wave, QRS) Axis as a Predictor of Mortality in 14 Years in a Population With a High Prevalence of Chagas Disease from the Bambuí Cohort Study of Aging. American Journal of Cardiology 121(3): 364-369, 2018

Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. European Journal of Clinical Pharmacology 73(5): 615-621, 2017

Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: Bambui Health and Aging Study (BHAS) FT Prevalencia e caracteristicas sociodemograficas associadas ao uso de benzodiazepinicos por idosos residentes na comunidade: Projeto Bambui. 2008

Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study. Revista Brasileira de Psiquiatria 38(3): 183-189, 2016

Comparing the value of BNP in predicting mortality among community-dwelling elderly with and without overweight/obesity: the Bambuí (Brazil) Cohort Study of Aging. International Journal of Cardiology 168(4): 4364-4366, 2013

Predictors of 10-year hospital use in a community-dwelling population of Brazilian elderly: the Bambuí Cohort Study of Aging. Cadernos de Saude Publica 27(Suppl. 3): S336, 2011

Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Revista Brasileira de Psiquiatria 30(1): 7-11, 2008